Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Imagine Institute
Blueprint Medicines Corporation
National Institutes of Health Clinical Center (CC)
Cogent Biosciences, Inc.
University Health Network, Toronto
University of Zurich